Tesofensine Protocol
Dosing & Research
Last Updated: September 4, 2026
Obesity pharmacology, Monoamine reuptake inhibition, Appetite suppression studies, Weight-loss trials
Half-Life
Long; often cited around 9 days for active moieties
Administration
Oral
Frequency
Once Daily, Morning Preferred
How It Works
- Obesity pharmacology
- Monoamine reuptake inhibition
- Appetite suppression studies
- Weight-loss trials
Dosing Structure
Dose
0.25–0.5 mg once daily
Frequency
Once Daily, Morning Preferred
Notes
Long Half-life Means Effects Persist Weeks After Stopping.
Example Protocols
Dose: 0.25–0.5 mg once daily
Frequency: Once Daily, Morning Preferred
Duration: 12-24 weeks
Off Period: Not listed
Find Research Grade Tesofensine
Recommended vendors for sourcing research-grade material. PeptaBase does not sell peptides directly.
Vendor One Research Labs
COA VerifiedThird-party COA-verified research peptides with published batch testing.
Source Coming SoonVendor Two Sciences
Purity TestedUS-based research compound supplier with independent purity testing.
Source Coming SoonVendor Three Peptide Co.
Bulk research peptide sourcing with batch-level documentation.
Source Coming SoonProtocol Notes
•
Long half-life means effects persist weeks after stopping.
Research & Studies
Loading citations…
Research Feedback
0 approved
For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.
Be the first to submit research feedback for this peptide.
Approved submissions will appear here as aggregated insights.